NON-HDL-CHOLESTEROL AND RELATED FACTORS IN PATIENT WITH TYPE 2 DIABETES AT CAN THO UNIVERSITY OF MEDICINE AND PHARMACY HOSPITAL
Main Article Content
Abstract
Background: The non-HDL-C index has a higher diagnostic value and greater integrity compared to the LDL-C index in diagnosing lipid disorders and predicting cardiovascular complications. Besides cardiovascular complications, lipid disorders are also closely associated with other conditions such as diabetes mellitus (DM), one of the most severe chronic diseases globally. Objectives: (i) To investigate the non-HDL-C levels in patients with type 2 diabetes mellitus at Can Tho University of Medicine and Pharmacy Hospital; (ii) To examine some factors related to plasma non-HDL-C levels in patients with type 2 diabetes mellitus at Can Tho University of Medicine and Pharmacy Hospital. Methods: A cross-sectional descriptive study was conducted on 236 patients with type 2 diabetes mellitus at Can Tho University of Medicine and Pharmacy Hospital. Results: The levels and rates of abnormalities in blood lipid parameters: TC, TG, LDL-C, HDL-C, and non-HDL-C were 5.25 ± 1.53 (48.3%), 2.81 ± 2.29 (68.6%), 2.94 ± 1.28 (38.1%), 1.19 ± 0.42 (39%), and 4.06 ± 1.46 (44.5%). Among overweight-obese patients, non-smokers, and those with elevated LDL-C, the rate of increased non-HDL-C was higher compared to non-overweight-obese patients, smoking habit, and those with optimal LDL-C levels, with a statistically significant difference (p<0.05). Conclusion: The non-HDL-C level in patients with type 2 diabetes mellitus was 4.06 ± 1.46 (44.5%). Factors associated with increased non-HDL-C levels included overweight-obesity, elevated LDL-C, and smoking. However, there was an inverse correlation observed between non-smokers and increased non-HDL-C levels
Article Details
Keywords
non-HDL-C; type 2 diabetes; Factors relation; Can Tho University of Medicine and Pharmacy Hospital.
References
2. Bộ Y tế (2022), Hội thảo trực tuyến công bố "Báo cáo Khảo sát hành vi sức khỏe học sinh toàn cầu tại Việt Nam năm 2019", Hà Nội.
3. Nguyễn Thị Hoa, Nguyễn Thị Ngọc Huyền (2021), “Nồng độ non-HDL- Cholesterol ở bệnh nhân đái tháo đường tuýp 2 tại Bệnh viện Trường Đại học Y DượcThái Nguyên”, Tạp chí Y học dự phòng Việt Nam, Tập 31 (9).
4. Vũ Thị Thanh Huyền, Hà Trần Hưng, Khúc Thị Hương (2015), “Nghiên cứu đặc điểm các chỉ số lipid máu và non-HDL-Cholesterol ở bệnh nhân đái tháo đường cao tuổi có yếu tố nguy cơ tim mạch”, Tạp chí Y Dược học Quân sự (4).
5. Hoàng Văn Sỹ, Lê Trung Hiếu, Nguyễn Tất Đạt, Nguyễn Minh Kha (2021), “Đặc điểm của nồng độ non-HDL-C ở bệnh nhân nhồi máu cơ tim cấp”, Tạp chí Y học TP. Hồ Chí Minh, Tập 25 (2).
6. Agarwal et al, “Association between glycemic control and serum lipid profile in known diabetic patients of civil hospital, Ahmedabad,” International Journal of Medical Science and Public Health, vol. 5, no. 2, pp. 356-360, 2016.Jamal S. Rana, S. Matthijs Boekholdt, John JP Kastelein, Prediman K. Shah (2011), “The Role of Non-HDL Cholesterol in Risk Stratification for Coronary Artery Disease”, National Institutes of Health, tập 14, 130-134.
7. Stuart S. Carr, Amanda J. Hooper, David R. Sullivan, John R. Burnett (2019), “Non-HDL-cholesterol and apolipoprotein B compared with LDL-cholesterol in atherosclerotic cardiovascular disease risk assessment”, National Institutes of Health, tập 51 (2), 148-154.